NDC 66689-009-01 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-009
- Requested NDC
- 66689-009-01
- Package NDCs from labels
- 66689-009-01, 66689-009-50
- Manufacturer
- VistaPharm, Inc.
- Effective date
- 2019-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IBUPROFEN ORAL SUSPENSION USP 100 mg/5 mL | VistaPharm, Inc. | 2019-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Ibuprofen - Cardinal Health | Cardinal Health | 2018-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-009-01 | ML - Milliliter | 66689-009 | 0607df43-62ad-450e-a5f3-6e1bae247e3b | 1 | 2013-02-13 |
| 66689-009-50 | ML - Milliliter | 66689-009 | 75797402-6277-490c-b6e6-fcd37a224737 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | XF417D3PSL |
| dg health ibuprofen | IBUPROFEN | Dolgencorp Inc | 98492b9f-8f48-42dd-b026-c37dcdc5f888 | 2024-01-08 | Warnings | WK2XYI10QM |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | b56ef662-fec2-4d94-e053-2995a90aba2b | 2024-01-06 | Warnings | 059QF0KO0R |
| IBUPROFEN CA | IBUPROFEN | TARGET CORPORATION | 8e8684fa-095e-c6d6-e053-2a95a90a15b4 | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e86ae68-7687-79d6-e053-2995a90ac274 | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e8646fe-fd62-1662-e053-2a95a90a3008 | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | TARGET CORPORATION | 8e872c8d-28e2-cd49-e053-2995a90a469f | 2024-01-03 | Warnings | WK2XYI10QM |
| Ibuprofen Mini | IBUPROFEN MINI 200 MG | TARGET CORPORATION | c80426d9-e121-c24d-e053-2a95a90acf2f | 2024-01-03 | Warnings | WK2XYI10QM |
| IBUPROFEN 200 MG | IBUPROFEN | Basic Drugs, Inc. | d3351d44-2078-3adc-e053-2995a90a3c8f | 2024-01-03 | Warnings | WK2XYI10QM |
| Exchange Select Maximum Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HCL | Army and Air Force Exchange Service | 318bc025-c936-a066-e063-6294a90a4712 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Kroger Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | The Kroger Co. | 318dea21-2656-36a3-e063-6294a90ac9c4 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Equaline Redness Relief Lubricant Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | United Natural Foods, Inc | 31a30b00-9f4b-717a-e063-6394a90a8a87 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Harris Teeter Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Harris Teeter, LLC. | 31a3d575-10f1-5feb-e063-6294a90ac478 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Discount Drug Mart Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Discount Drug Mart, Inc. | 31a98e6c-42df-6b56-e063-6294a90a3564 | 2024-01-01 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | 59f14d2b-f48a-4c25-bea3-3dc9100898b2 | 2023-12-31 | Warnings | WK2XYI10QM |
| Ibuprofen Pain Releiver/ Fever Reducer | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | ee241be0-35f8-4789-a71f-98de31d6a590 | 2023-12-31 | Warnings | WK2XYI10QM |
| Ibuprofen (NSAID) Pain Releiver/ Fever Reducer | IBUPROFEN | Amneal Pharmaceuticals of New York LLC | a8c6bc4e-1e48-4613-8cbf-8c5cd9d51ad0 | 2023-12-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Amneal Pharmaceuticals NY LLC | e07d989d-1b0e-4cc1-abf2-93c8b208a29a | 2023-12-30 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | DEMOULAS SUPERMARKETS INC. | 4ca54293-9e81-4b24-8112-734f28cd2c55 | 2023-12-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Bionpharma Inc. | 4bc6e8f2-ba95-4352-80ed-b44608fc4936 | 2023-12-27 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.